Interventional Cardiology Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation

نویسندگان

  • Ignacio Ferreira-González
  • Josep R. Marsal
  • Salvatore Brugaletta
  • Mari L. Capote
چکیده

Ignacio Ferreira-González, MD, PhD; Josep R. Marsal, BSc; Aida Ribera, PhD; Gaietà Permanyer-Miralda, MD, PhD; Bruno Garcı́a-Del Blanco, MD; Gerard Martı́, MD; Purificación Cascant, RN; Victoria Martı́n-Yuste, MD; Salvatore Brugaletta, MD; Manuel Sabaté, MD, PhD; Fernando Alfonso, MD, PhD; Mari L. Capote, MD; Jose M. De La Torre, MD, PhD; Marta Ruı́z-Lera, MD; Dario Sanmiguel, MD; Mérida Cárdenas, MD; Beth Pujol, RN; Jose A. Baz, MD; Andrés Iñiguez, MD; Ramiro Trillo, MD; Omar González-Béjar, MD; Juan Casanova, MD; Joaquı́n Sánchez-Gila, MD; David Garcı́a-Dorado, MD, PhD

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Clopidogrel Therapy Discontinuation Following Drug Eluting Stent Implantation in Real World Practice in Israel

BACKGROUND Incidence and predictors of clopidogrel discontinuation after drug eluting stent (DES) implantation, in real world practice, are poorly known. METHODS Prospective study included all patients who underwent implantation of at least one DES between February 2006 and January 2007. Predictors of clopidogrel discontinuation were assessed by a multivariable analysis. RESULTS In 269 pati...

متن کامل

Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year.

OBJECTIVES The goal of this study was to assess the risk associated with double antiplatelet therapy (DAT) discontinuation, and specifically, temporary discontinuation, during the first year after drug-eluting stent (DES) implantation. BACKGROUND Doubts remain about the risk of temporary DAT discontinuation within 1 year after DES implantation. METHODS A total of 1,622 consecutive patients ...

متن کامل

Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.

BACKGROUND Predictors of antiplatelet therapy discontinuation (ATD) during the first year after drug-eluting stent implantation are poorly known. METHODS AND RESULTS This was a prospective study with 3-, 6-, 9-, and 12-month follow-up of patients receiving at least 1 drug-eluting stent between January and April 2008 in 29 hospitals. Individual- and hospital-level predictors of ATD were assess...

متن کامل

Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.

Despite concerns regarding the long-term safety of drug-eluting stent (DES) implantation because of late-onset stent thrombosis, the actual incidence of stent thrombosis after 1 year is unknown. We investigated the incidence, risk factors, and association of antiplatelet therapy interruption for the development of stent thrombosis after DES implantation during long-term follow-up. A total of 1,...

متن کامل

Simultaneous Thrombosis of Two Drug-Eluting Stents After Discontinuation of Dual Antiplatelet Therapy for a Day

Stent thrombosis is rare but can lead to potential severe consequence. The incidence is relative higher in drug-eluting sent than bare-metal stent implantation. Dual antiplatelet therapy is the major treatment to avoid early and late stent thrombosis. Simultaneous two stents thrombosis is rare. Although mechanical or/and procedure factors may predispose to stent thrombosis occurred, simultaneou...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010